Medpace Holdings, Inc. (MEDP)
537.54
-0.38
(-0.07%)
USD |
NASDAQ |
Jul 17, 16:00
537.54
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Gross Profit Margin (Quarterly) : 26.81% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 26.81% |
| December 31, 2025 | 27.97% |
| September 30, 2025 | 28.78% |
| June 30, 2025 | 28.67% |
| March 31, 2025 | 30.69% |
| December 31, 2024 | 31.83% |
| September 30, 2024 | 30.28% |
| June 30, 2024 | 27.76% |
| March 31, 2024 | 28.99% |
| December 31, 2023 | 26.05% |
| September 30, 2023 | 25.65% |
| June 30, 2023 | 25.56% |
| March 31, 2023 | 28.62% |
| December 31, 2022 | 27.87% |
| September 30, 2022 | 29.51% |
| June 30, 2022 | 26.61% |
| March 31, 2022 | 28.27% |
| December 31, 2021 | 26.74% |
| September 30, 2021 | 27.66% |
| June 30, 2021 | 24.95% |
| March 31, 2021 | 28.21% |
| December 31, 2020 | 29.79% |
| Date | Value |
|---|---|
| September 30, 2020 | 30.05% |
| June 30, 2020 | 25.36% |
| March 31, 2020 | 26.26% |
| December 31, 2019 | 24.96% |
| September 30, 2019 | 27.34% |
| June 30, 2019 | 27.47% |
| March 31, 2019 | 23.51% |
| December 31, 2018 | 26.67% |
| September 30, 2018 | 25.40% |
| June 30, 2018 | 25.77% |
| March 31, 2018 | 22.15% |
| December 31, 2017 | 28.65% |
| September 30, 2017 | 30.55% |
| June 30, 2017 | 29.22% |
| March 31, 2017 | 29.17% |
| December 31, 2016 | 27.41% |
| September 30, 2016 | 26.91% |
| June 30, 2016 | 27.31% |
| March 31, 2016 | 26.49% |
| December 31, 2015 | 27.78% |
| September 30, 2015 | 24.41% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avantor, Inc. | 31.66% |
| Adaptive Biotechnologies Corp. | 70.56% |
| 10X Genomics, Inc. | 71.09% |
| IQVIA Holdings, Inc. | 25.85% |
| Charles River Laboratories International, Inc. | 30.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 108.7% |
| Return on Assets | 24.68% |
| Return on Invested Capital | 80.94% |
| Profit Margin (Quarterly) | 17.53% |
| Operating Margin (Quarterly) | 20.03% |
| Return on Net Operating Assets | 34.78% |